Lv1
28 积分 2025-12-09 加入
Preliminary efficacy and safety of disitamab vedotin (DV) combined with bacillus Calmette-Guérin (BCG) in the treatment of high-risk non-muscle invasive bladder cancer with HER2 expression: A prospective, open label, single-center study
3天前
已完结
Updated efficacy and safety of SHR-1501, an IL-15RαFc superagonist, with or without Bacille Calmette Guerin (BCG) for high-risk non-muscle invasive bladder cancer (NMIBC): A phase 1/2 study
3天前
已完结
Machine-intelligent multimodal algebot for intracavitary chemotherapy
3个月前
已完结
A self-assembled fluorescent contrast agent targeting XIAP for image-guided surgery of bladder cancer
4个月前
已完结
FomA‐Containing Outer Membrane Vesicles of Fusobacterium Nucleatum Facilitate Bladder Cancer Lymphatic Metastasis via IL‐6‐Dependent M2b Macrophage Polarization
6个月前
已完结
CD133 and CD44 as cancer stem cell markers in bladder carcinoma
7个月前
已完结
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer
7个月前
已完结
Tumor microenvironment responsive drug delivery systems
8个月前
已完结
The mechanism of action of BCG therapy for bladder cancer—a current perspective
9个月前
已完结
Aptamer-controlled stimuli-responsive drug release
9个月前
已完结
皖公网安备34019202002308
